Skip to main content
Devonian Health Group Inc logo

Devonian Health Group Inc — Investor Relations & Filings

Ticker · GSD ISIN · CA2518341078 TSXV Manufacturing
Open in API
Filings indexed 598 across all filing types
Latest filing 2021-12-10 Regulatory Filings
Country CA Canada
Listing TSXV GSD

About Devonian Health Group Inc

https://groupedevonian.com/

Devonian Health Group Inc. is a clinical-stage botanical pharmaceutical company specializing in the development of novel prescription therapeutic solutions for unmet medical needs. The core business involves late-stage prescription botanical drugs targeting fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. The company utilizes a broad-based technology platform, originating from over 20 years of research, to develop therapies that target multiple cellular pathways and regulate genes linked to these diseases. Its pipeline includes the lead product candidate, Thykamine, currently in Phase 3 clinical trials. Devonian also develops high-value dermatological products alongside its core drug development activities.

Recent filings

Filing Released Lang Actions
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2021-12-10 English
Material change report - French.pdf
Regulatory Filings
2021-12-10 English
News release - French.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the publication of a scientific article about the potential use of the company's botanical drug Thykamine for treating Covid-19. It includes background information about the company, the drug, and the article, but does not contain any financial data, regulatory filings, or corporate governance information. It is not an annual report, earnings release, management report, or any other financial or regulatory filing. It is also not a presentation, call transcript, or voting announcement. The document is essentially a news announcement about a scientific publication related to the company's product. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2021-12-08 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the publication of a scientific article by Devonian Health Group's CEO about the potential use of their product Thykamine™ in treating Covid-19. It discusses the article's content, the company's product pipeline, and forward-looking statements. There is no financial data, regulatory filing, or report attached or referenced as being published. The document is an announcement of a publication and company news rather than a financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any regulatory filing. It is a general corporate announcement about a scientific publication and company product development. Therefore, the best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous announcements that do not fit other categories.
2021-12-08 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of an oversubscribed private placement financing by Devonian Health Group Inc. It details the amount raised, the terms of the units issued, the use of proceeds, and related party transactions. There is no financial statement data, no detailed financial performance analysis, nor is it a transcript or management report. The content focuses on capital raising activities and financing updates. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing event, not just an announcement of a report publication or a regulatory filing. Hence, the classification is CAP with high confidence.
2021-11-30 English
News release - French.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the closing of a private placement financing by Groupe Santé Devonian inc. It details the number of units issued, the price, the use of proceeds, and regulatory approvals related to the financing. There is no financial statement or detailed financial report included, nor is it an announcement of a report publication. The content focuses on capital raising activities and financing details. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing event, not just a brief announcement or certification.
2021-11-30 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.